Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cancer Research|January 10, 2019
HER2 CAR-T Cells Eradicate Uveal Melanoma and T-cell Therapy-Resistant Human Melanoma in IL2 Transgenic NOD/SCID IL2 Receptor Knockout MiceElin M V Forsberg, Mattias F Lindberg, Henrik Jespersen, et al.
BMC Cancer|May 4, 2019
Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label studyHenrik Jespersen, Roger Olofsson Bagge, Gustav Ullenhag, et al.
Oncotarget|September 18, 2014
Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisionsBerglind O Einarsdottir, Roger Olofsson Bagge, Joydeep Bhadury, et al.
Cancer Research Communications|June 28, 2023
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint ImmunotherapyVasu R Sah, Henrik Jespersen, Joakim Karlsson, et al.
Nature Communications|April 22, 2020
Molecular profiling of driver events in metastatic uveal melanomaJoakim Karlsson, Lisa M Nilsson, Suman Mitra, et al.
Nature Communications|August 28, 2021
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanomaLars Ny, Henrik Jespersen, Joakim Karlsson, et al.
Frontiers in Oncology|May 20, 2026
CD38<sup>hi</sup>CD19<sup>dim</sup> cells in lymph nodes predict favorable prognosis in patients with stage III melanoma receiving adjuvant PD-1-blockadeIeva Ailte, Sudhir Kumar Chauhan, Lina Prasmickaite, et al.
JCO Precision Oncology|September 11, 2020
Mutational Signature and Transcriptomic Classification Analyses as the Decisive Diagnostic Tools for a Cancer of Unknown PrimaryRoger Olofsson Bagge, Akif Demir, Joakim Karlsson, et al.
Cell Death & Disease|February 8, 2020
Correction: A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanomaBerglind O Einarsdottir, Joakim Karlsson, Elin M V Söderberg, et al.
Cell Death & Disease|July 26, 2018
A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanomaBerglind O Einarsdottir, Joakim Karlsson, Elin M V Söderberg, et al.
Pageof 2